We are very excited to announce the partnership with Cosmos Holdings (NASDAQ:COSM), to develop new products targeting the gut microbiome. Our mission is closely aligned with Cosmos, as they are devoted to developing new and innovative products using high-quality natural ingredients.

https://www.nasdaq.com/press-release/cosmos-holdings-announces-strategic-rd-partnership-with-cloudpharm-p.c.-to-study-the